Freestone Grove Partners »

Lenz Therapeutics shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $368k 23k 16.00

More positions owned by Freestone Grove Partners

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Boston Scientific Corporation (BSX)
Ametek (AME)
Encana Corporation (OVV)
First Horizon National Corporation (FHN)
Charles Schwab Corporation (SCHW)
Anthem (ELV)
MasTec (MTZ)
Fortune Brands (FBIN)
Xcel Energy (XEL)
Lennar Corp Cl A (LEN)
Martin Marietta Materials (MLM)
Danaher Corporation (DHR)

View all positions for Freestone Grove Partners

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics